These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characterizing the mucin-degrading capacity of the human gut microbiota. Glover JS; Ticer TD; Engevik MA Sci Rep; 2022 May; 12(1):8456. PubMed ID: 35589783 [TBL] [Abstract][Full Text] [Related]
7. Furtado KL; Plott L; Markovetz M; Powers D; Wang H; Hill DB; Papin J; Allbritton NL; Tamayo R mSphere; 2024 Jun; 9(6):e0008124. PubMed ID: 38837404 [TBL] [Abstract][Full Text] [Related]
8. Human intestinal enteroids as a model of Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302 [No Abstract] [Full Text] [Related]
9. Revealing Glycosylation Patterns in de Ram C; van der Lugt B; Elzinga J; Geerlings S; Steegenga WT; Belzer C; Schols HA J Agric Food Chem; 2024 Jul; 72(27):15345-15356. PubMed ID: 38932522 [TBL] [Abstract][Full Text] [Related]
11. The role of mucin Fekete E; Buret AG Am J Physiol Gastrointest Liver Physiol; 2023 Jun; 324(6):G452-G465. PubMed ID: 37070751 [TBL] [Abstract][Full Text] [Related]
12. A Continuous Battle for Host-Derived Glycans Between a Mucus Specialist and a Glycan Generalist Kostopoulos I; Aalvink S; Kovatcheva-Datchary P; Nijsse B; Bäckhed F; Knol J; de Vos WM; Belzer C Front Microbiol; 2021; 12():632454. PubMed ID: 34248864 [TBL] [Abstract][Full Text] [Related]
13. Intestinal mucus and their glycans: A habitat for thriving microbiota. Luis AS; Hansson GC Cell Host Microbe; 2023 Jul; 31(7):1087-1100. PubMed ID: 37442097 [TBL] [Abstract][Full Text] [Related]
15. Mucin glycans and their degradation by gut microbiota. Yamaguchi M; Yamamoto K Glycoconj J; 2023 Aug; 40(4):493-512. PubMed ID: 37318672 [TBL] [Abstract][Full Text] [Related]
17. Genome-Scale Model and Omics Analysis of Metabolic Capacities of Ottman N; Davids M; Suarez-Diez M; Boeren S; Schaap PJ; Martins Dos Santos VAP; Smidt H; Belzer C; de Vos WM Appl Environ Microbiol; 2017 Sep; 83(18):. PubMed ID: 28687644 [TBL] [Abstract][Full Text] [Related]
19. Optimization of an Assay To Determine Colonization Resistance to Clostridioides difficile in Fecal Samples from Healthy Subjects and Those Treated with Antibiotics. Harris HC; Best EL; Normington C; Saint-Lu N; Sablier-Gallis F; de Gunzburg J; Andremont A; Wilcox MH; Chilton CH Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139292 [TBL] [Abstract][Full Text] [Related]
20. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile. Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]